Analysis of ChIP data of responsive and nonresponsive breast tumors[7] revealed significant differential ERα binding at several of these loci, with 10 of 27 showing increased binding in the nonresponsive setting (Figure 3B). The gene discussed is ESR1; the disease is breast neoplasm.